References
Joannes-Boyau O, Honoré P, Perez P et al (2013) High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicenter randomized controlled trial. Intens Care Med. doi:10.1007/s00134-013-2967-z
Friedlin B, Korn EL (2009) Stopping clinical trials early for benefit: impact on estimation. Clin Trials 6:119–125
Sargent D (2009) Early stopping for benefit in National Cancer Institute-sponsored phase III trials: the system is working. J Clin Oncol 27(10):1543–1544
Korn EL, Friedlin B, Mooney M (2009) Stopping or reporting early for positive results in randomized clinical trials: the National Cancer Institute cooperative group experience from 1990 to 2005. J Clin Oncol 27(10):1712–1721
Montori VM, Devereaux PJ, Adhikari NKJ et al (2005) Randomized trials stopped early for benefit. A systematic review. JAMA 294(17):2203–2209
Berry SM, Carlin BP, Connor J (2010) Bias and trials stopped early for benefit. Letters to the Editor. JAMA 304(2):156–159
Ware JH, Muller JE, Braunwald E (1985) The futility index. An approach to cost-effective termination of randomized clinical trials. Am J Med 78(4):635–643
DeMets DL (2006) Futility approaches to interim monitoring by data monitoring committees. Clin Trial 3:522–529
Conflicts of interest
The author states that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Leandro, G. How to interpret a randomized controlled study stopped early. Intensive Care Med 39, 1642–1643 (2013). https://doi.org/10.1007/s00134-013-3000-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-013-3000-2